Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX)

References

• Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012;6:1–11. doi:10.2147/PPA.S29716.
   PubMed Web of Science ®Google Scholar
• Perera S, Eisen R, Bhatt M, et al. Light therapy for non-seasonal depression: systematic review and meta-analysis. BJPsych Open. 2016;2(2):116–126. doi:10.1192/bjpo.bp.115.001610.
   PubMed Web of Science ®Google Scholar
• Dong C, Shi H, Liu P, et al. A critical overview of systematic reviews and meta-analyses of light therapy for non-seasonal depression. Psychiatry Res. 2022;314:114686. doi:10.1016/j.psychres.2022.114686.
   PubMed Web of Science ®Google Scholar
• Campbell PD, Miller AM, Woesner ME. Bright light therapy: seasonal affective disorder and beyond. Einstein J Biol Med. 2017;32:E13–E25.
   PubMedGoogle Scholar
• Athira KV, Bandopadhyay S, Samudrala PK, et al. An overview of the heterogeneity of major depressive disorder: current knowledge and future prospective. CN. 2020;18(3):168–187. doi:10.2174/1570159X17666191001142934.
   Google Scholar
• Li B, Friston K, Mody M, et al. A brain network model for depression: from symptom understanding to disease intervention. CNS Neurosci Ther. 2018;24(11):1004–1019. doi:10.1111/cns.12998.
   PubMed Web of Science ®Google Scholar
• Wise T, Marwood L, Perkins AM, et al. Instability of default mode network connectivity in major depression: a two-sample confirmation study. Transl Psychiatry. 2017;7(4):e1105. doi:10.1038/tp.2017.40.
   PubMedGoogle Scholar
• Yan C-G, Chen X, Li L, et al. Reduced default mode network functional connectivity in patients with recurrent major depressive disorder. Proc Natl Acad Sci U S A. 2019;116(18):9078–9083. doi:10.1073/pnas.1900390116.
   PubMed Web of Science ®Google Scholar
• Guàrdia-Olmos J, Soriano-Mas C, Tormo-Rodríguez L, et al. Abnormalities in the default mode network in late-life depression: a study of resting-state fMRI. Int J Clin Health Psychol. 2022;22(3):100317. doi:10.1016/j.ijchp.2022.100317.
   PubMed Web of Science ®Google Scholar
• Ho TC, Connolly CG, Henje Blom E, et al. Emotion-dependent functional connectivity of the default mode network in adolescent depression. Biol Psychiatry. 2015;78(9):635–646. doi:10.1016/j.biopsych.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Michel CM, Pascual-Leone A. Predicting antidepressant response by electroencephalography. Nat Biotechnol. 2020;38(4):417–419. doi:10.1038/s41587-020-0476-5.
   PubMed Web of Science ®Google Scholar
• Wu W, Zhang Y, Jiang J, et al. An electroencephalographic signature predicts antidepressant response in major depression. Nat Biotechnol. 2020;38(4):439–447. doi:10.1038/s41587-019-0397-3.
   PubMed Web of Science ®Google Scholar
• Bilge MT, Gosai AK, Widge AS. Deep brain stimulation in psychiatry. Psychiatr Clin North Am. 2018;41(3):373–383. doi:10.1016/j.psc.2018.04.003.
   PubMed Web of Science ®Google Scholar
• Haller N, Senner F, Brunoni AR, et al. Gamma transcranial alternating current stimulation improves mood and cognition in patients with major depression. J Psychiatr Res. 2020;130:31–34. doi:10.1016/j.jpsychires.2020.07.009.
   PubMed Web of Science ®Google Scholar
• Ma Y, Rosenheck R, Ye B, et al. Effectiveness of electroconvulsive therapy in patients with “less treatment-resistant” depression by the Maudsley Staging Model. Brain Behav. 2020;10(7):e01654. doi:10.1002/brb3.1654.
   PubMed Web of Science ®Google Scholar
• Martiny K, Lunde M, Bech P. Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression. Biol Psychiatry. 2010;68(2):163–169. doi:10.1016/j.biopsych.2010.02.017.
   PubMed Web of Science ®Google Scholar
• Buzsáki G, Logothetis N, Singer W. Scaling brain size, keeping timing: evolutionary preservation of brain rhythms. Neuron. 2013;80(3):751–764. doi:10.1016/j.neuron.2013.10.002.
   PubMed Web of Science ®Google Scholar
• Alexander ML, Alagapan S, Lugo CE, et al. Double-blind, randomized pilot clinical trial targeting alpha oscillations with transcranial alternating current stimulation (tACS) for the treatment of major depressive disorder (MDD). Transl Psychiatry. 2019;9(1):106. doi:10.1038/s41398-019-0439-0.
   PubMedGoogle Scholar
• Adaikkan C, Middleton SJ, Marco A, et al. Gamma entrainment binds higher order brain regions and offers neuroprotection. Neuron. 2019;102(5):929–943.e8. doi:10.1016/j.neuron.2019.04.011.
   PubMed Web of Science ®Google Scholar
• Lee K, Park Y, Suh SW, et al. Optimal flickering light stimulation for entraining gamma waves in the human brain. Sci Rep. 2021;11(1):16206. doi:10.1038/s41598-021-95550-1.
   PubMed Web of Science ®Google Scholar
• Tian T, Qin X, Wang Y, et al. 40 Hz light flicker promotes learning and memory via long term depression in wild-type mice. J Alzheimers Dis. 2021;84(3):983–993. doi:10.3233/jad-215212.
   PubMed Web of Science ®Google Scholar
• Buzsáki G, Moser EI. Memory, navigation and theta rhythm in the hippocampal-entorhinal system. Nat Neurosci. 2013;16(2):130–138. doi:10.1038/nn.3304.
   PubMed Web of Science ®Google Scholar
• Buzsáki G. Hippocampal sharp wave‐ripple: a cognitive biomarker for episodic memory and planning. Hippocampus. 2015;25(10):1073–1188. doi:10.1002/hipo.22488.
   PubMed Web of Science ®Google Scholar
• Chan D, Suk H-J, Jackson BL, et al. Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: results of feasibility and pilot studies. PLoS One. 2022;17(12):e0278412. doi:10.1371/journal.pone.0278412.
   PubMed Web of Science ®Google Scholar
• Colgin LL, Moser EI. Gamma oscillations in the hippocampus. Physiology (Bethesda). 2010;25(5):319–329. doi:10.1152/physiol.00021.2010.
   PubMed Web of Science ®Google Scholar
• Groves SJ, Douglas KM, Porter RJ. A systematic review of cognitive predictors of treatment outcome in major depression. Front Psychiatry. 2018;9:382. doi:10.3389/fpsyt.2018.00382.
   PubMed Web of Science ®Google Scholar
• Rostami R, Kazemi R, Nasiri Z, et al. Cold cognition as predictor of treatment response to rTMS; a retrospective study on patients with unipolar and bipolar depression. Front Hum Neurosci. 2022;16:888472. doi:10.3389/fnhum.2022.888472.
   PubMed Web of Science ®Google Scholar
• Park S-S, Park H-S, Kim C-J, et al. Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease. Alzheimers Res Ther. 2020;12:62. doi:10.1186/s13195-020-00631-4.
   PubMed Web of Science ®Google Scholar
• Singer AC, Martorell AJ, Douglas JM, et al. Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load. Nat Protoc. 2018;13(8):1850–1868. doi:10.1038/s41596-018-0021-x.
   PubMed Web of Science ®Google Scholar
• Iaccarino HF, Singer AC, Martorell AJ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230–235. doi:10.1038/nature20587.
   PubMed Web of Science ®Google Scholar
• Martorell AJ, Paulson AL, Suk H-J, et al. Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell. 2019;177(2):256–271.e22. doi:10.1016/j.cell.2019.02.014.
   PubMed Web of Science ®Google Scholar
• Chan D, Suk H-J, Jackson B, et al. 40Hz sensory stimulation induces gamma entrainment and affects brain structure, sleep and cognition in patients with Alzheimer’s dementia. medRxiv. 2021. doi:10.1101/2021.03.01.21252717.
   Google Scholar
• Cimenser A, Hempel E, Travers T, et al. Sensory-evoked 40-Hz gamma oscillation improves sleep and daily living activities in Alzheimer’s disease patients. Front Syst Neurosci. 2021;15:746859. doi:10.3389/fnsys.2021.746859.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–33.
   PubMed Web of Science ®Google Scholar
• Brown TM. Melanopic illuminance defines the magnitude of human circadian light responses under a wide range of conditions. J Pineal Res. 2020;69(1):e12655. doi:10.1111/jpi.12655.
   PubMed Web of Science ®Google Scholar
• Do MTH. Melanopsin and the intrinsically photosensitive retinal ganglion cells: biophysics to behavior. Neuron. 2019;104(2):205–226. doi:10.1016/j.neuron.2019.07.016.
   PubMed Web of Science ®Google Scholar
• Pickard GE, Sollars PJ. Intrinsically photosensitive retinal ganglion cells. Rev Physiol Biochem Pharmacol. 2012;162:59–90. doi:10.1007/112_2011_4.
   PubMed Web of Science ®Google Scholar
• CIE. CIE S 026/E:2018 CIE system for metrology of optical radiation for ipRGC-influenced responses to light. Vienna, Austria: International Commission on Illumination (CIE); 2018. doi:10.25039/S026.2018.
   Google Scholar
• Timmerby N, Andersen JH, Søndergaard S, et al. A systematic review of the clinimetric properties of the 6-item version of the Hamilton depression rating scale (HAM-D6). Psychother Psychosom. 2017;86(3):141–149. doi:10.1159/000457131.
   PubMed Web of Science ®Google Scholar
• Kyle PR, Lemming OM, Timmerby N, et al. The validity of the different versions of the Hamilton depression scale in separating remission rates of placebo and antidepressants in clinical trials of major depression. J Clin Psychopharmacol. 2016;36(5):453–456. doi:10.1097/JCP.0000000000000557.
   PubMed Web of Science ®Google Scholar
• Bech P, Timmerby N, Martiny K, et al. Psychometric evaluation of the major depression inventory (MDI) as depression severity scale using the LEAD (longitudinal expert assessment of all data) as index of validity. BMC Psychiatry. 2015;15(1):190. doi:10.1186/s12888-015-0529-3.
   PubMed Web of Science ®Google Scholar
• Godlewska BR, Harmer CJ. Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment. Psychopharmacology (Berl). 2021;238(5):1265–1278. doi:10.1007/s00213-019-05448-0.
   PubMed Web of Science ®Google Scholar
• Seeberg I, Kjaerstad HL, Miskowiak KW. Neural and behavioral predictors of treatment efficacy on mood symptoms and cognition in mood disorders: a systematic review. Front Psychiatry. 2018;9:337. doi:10.3389/fpsyt.2018.00337.
   PubMed Web of Science ®Google Scholar
• Meluken I, Ottesen NM, Harmer CJ, et al. Is aberrant affective cognition an endophenotype for affective disorders? - A monozygotic twin study. Psychol Med. 2019;49:987–996. doi:10.1017/S0033291718001642.
   PubMed Web of Science ®Google Scholar
• Purdon PS. The screen for cognitive impairment in psychiatry: administration and psychometric properties. Alberta, Canada: PNL Inc; 2005.
   Google Scholar
• Ott CV, Knorr U, Jespersen A, et al. Norms for the screen for cognitive impairment in psychiatry and cognitive trajectories in bipolar disorder. J Affect Disord. 2021;281:33–40. doi:10.1016/j.jad.2020.11.119.
   PubMed Web of Science ®Google Scholar
• Army Individual Test Battery. Manual of directions and scoring. Washington (DC): War Department, Adjunct General’s Office; 1944.
   Google Scholar
• Tourjman SV, Juster R-P, Purdon S, et al. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression. Int J Psychiatry Clin Pract. 2019;23(1):49–56. doi:10.1080/13651501.2018.1450512.
   PubMed Web of Science ®Google Scholar
• Fernández-Palleiro P, Rivera-Baltanás T, Rodrigues-Amorim D, et al. Brainwaves oscillations as a potential biomarker for major depression disorder risk. Clin EEG Neurosci. 2020;51(1):3–9. doi:10.1177/1550059419876807.
   PubMed Web of Science ®Google Scholar
• Hieronymus F, Jauhar S, Østergaard SD, et al. One (effect) size does not fit at all: interpreting clinical significance and effect sizes in depression treatment trials. J Psychopharmacol. 2020;34(10):1074–1078. doi:10.1177/0269881120922950.
   PubMed Web of Science ®Google Scholar
• Passarelli M, Masini M, Bracco F, et al. Development and validation of the facial expression recognition test (FERT). Psychol Assess. 2018;30(11):1479–1490. doi:10.1037/pas0000595.
   PubMed Web of Science ®Google Scholar
• Mahurin RK, Velligan DI, Hazleton B, et al. Trail making test errors and executive function in schizophrenia and depression. Clin Neuropsychol. 2006;20(2):271–288. doi:10.1080/13854040590947498.
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, et al. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi:10.1016/0165-1781(89)90047-4.
   PubMed Web of Science ®Google Scholar
• Topp CW, Østergaard SD, Søndergaard S, et al. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167–176. doi:10.1159/000376585.
   PubMed Web of Science ®Google Scholar
• Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334(s334):1–100. doi:10.1111/j.1600-0447.1987.tb10566.x.
   PubMedGoogle Scholar
• van Spijker BAJ, Batterham PJ, Calear AL, et al. The suicidal ideation attributes scale (SIDAS): community-based validation study of a new scale for the measurement of suicidal ideation. Suicide Life Threat Behav. 2014;44(4):408–419. doi:10.1111/sltb.12084.
   PubMed Web of Science ®Google Scholar
• Lukasiewicz M, Gerard S, Besnard A, et al. Young mania rating scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. Int J Methods Psychiatr Res. 2013;22(1):46–58. doi:10.1002/mpr.1379.
   PubMed Web of Science ®Google Scholar